In June 2023, RANZCP launched a clinical memorandum “Therapeutic Use of copyright Substances”. The objective of the memo was to tell psychiatrists with regards to the opportunity therapeutic use of copyright substances to support the treatment of mental illness. Evaluate that to LSD,